CN103623404B - 一种b型流感嗜血杆菌多糖结合疫苗的制备方法 - Google Patents
一种b型流感嗜血杆菌多糖结合疫苗的制备方法 Download PDFInfo
- Publication number
- CN103623404B CN103623404B CN201210311027.3A CN201210311027A CN103623404B CN 103623404 B CN103623404 B CN 103623404B CN 201210311027 A CN201210311027 A CN 201210311027A CN 103623404 B CN103623404 B CN 103623404B
- Authority
- CN
- China
- Prior art keywords
- prp
- ethanol
- preparation
- add
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010022000 influenza Diseases 0.000 title claims abstract description 48
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 46
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 150000004676 glycans Chemical class 0.000 title claims abstract description 21
- 108010060123 Conjugate Vaccines Proteins 0.000 title claims abstract description 12
- 229940031670 conjugate vaccine Drugs 0.000 title claims abstract description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 123
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 48
- 239000000243 solution Substances 0.000 claims abstract description 28
- -1 PRP polysaccharide Chemical class 0.000 claims abstract description 26
- 239000011780 sodium chloride Substances 0.000 claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 18
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000000502 dialysis Methods 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 8
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 7
- 239000012498 ultrapure water Substances 0.000 claims abstract description 7
- 239000008215 water for injection Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 110
- 229960004756 ethanol Drugs 0.000 claims description 50
- 238000000034 method Methods 0.000 claims description 44
- 239000002244 precipitate Substances 0.000 claims description 37
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 31
- 239000006228 supernatant Substances 0.000 claims description 29
- 229960005486 vaccine Drugs 0.000 claims description 21
- 235000012489 doughnuts Nutrition 0.000 claims description 17
- 238000001556 precipitation Methods 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 16
- 238000000108 ultra-filtration Methods 0.000 claims description 16
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- 239000012467 final product Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 11
- 230000001580 bacterial effect Effects 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000010828 elution Methods 0.000 claims description 11
- 239000012531 culture fluid Substances 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 10
- 238000011068 loading method Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 238000012549 training Methods 0.000 claims description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 9
- 239000012149 elution buffer Substances 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 7
- 239000008346 aqueous phase Substances 0.000 claims description 7
- 239000001110 calcium chloride Substances 0.000 claims description 7
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 7
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 7
- 238000010612 desalination reaction Methods 0.000 claims description 7
- 238000012869 ethanol precipitation Methods 0.000 claims description 7
- 239000013049 sediment Substances 0.000 claims description 7
- 239000001632 sodium acetate Substances 0.000 claims description 7
- 235000017281 sodium acetate Nutrition 0.000 claims description 7
- 229920002684 Sepharose Polymers 0.000 claims description 6
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 6
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 238000003501 co-culture Methods 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 206010013023 diphtheria Diseases 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 241000186216 Corynebacterium Species 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000011550 stock solution Substances 0.000 claims description 4
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims description 3
- 241000143437 Aciculosporium take Species 0.000 claims description 3
- 241000186227 Corynebacterium diphtheriae Species 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 3
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 238000005342 ion exchange Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 235000021110 pickles Nutrition 0.000 claims description 3
- 238000005204 segregation Methods 0.000 claims description 3
- 239000011534 wash buffer Substances 0.000 claims description 3
- 229940001007 aluminium phosphate Drugs 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229940047650 haemophilus influenzae Drugs 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 102100021503 ATP-binding cassette sub-family B member 6 Human genes 0.000 description 48
- 102000014914 Carrier Proteins Human genes 0.000 description 6
- 108010078791 Carrier Proteins Proteins 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 102000013275 Somatomedins Human genes 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000010413 mother solution Substances 0.000 description 4
- 230000002766 immunoenhancing effect Effects 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 description 2
- 229960004443 hemophilus influenzae b vaccines Drugs 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 101100046775 Arabidopsis thaliana TPPA gene Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 208000001606 epiglottitis Diseases 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006054 immunological memory Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210311027.3A CN103623404B (zh) | 2012-08-28 | 2012-08-28 | 一种b型流感嗜血杆菌多糖结合疫苗的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210311027.3A CN103623404B (zh) | 2012-08-28 | 2012-08-28 | 一种b型流感嗜血杆菌多糖结合疫苗的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103623404A CN103623404A (zh) | 2014-03-12 |
CN103623404B true CN103623404B (zh) | 2016-08-03 |
Family
ID=50205085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210311027.3A Active CN103623404B (zh) | 2012-08-28 | 2012-08-28 | 一种b型流感嗜血杆菌多糖结合疫苗的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103623404B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2770877C1 (ru) * | 2021-04-08 | 2022-04-22 | Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" | Способ получения антигенной конъюгированной субстанции гемофильного типа b микроба для создания вакцинных препаратов |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104096224B (zh) * | 2014-05-11 | 2020-06-19 | 江苏康泰生物医学技术有限公司 | 一种增强流行性嗜血杆菌b型多糖蛋白结合物免疫原性的方法 |
CN104096228B (zh) * | 2014-05-11 | 2020-06-19 | 江苏康泰生物医学技术有限公司 | 一种增强流行性嗜血杆菌b型多糖蛋白结合物免疫原性的方法 |
CN104225588B (zh) * | 2014-08-20 | 2016-06-22 | 北京智飞绿竹生物制药有限公司 | b型流感嗜血杆菌结合疫苗的制备方法 |
CN105056221A (zh) * | 2015-08-31 | 2015-11-18 | 成都欧林生物科技股份有限公司 | 利用a群脑膜炎球菌精糖制备多糖-adh衍生物的方法 |
CN105199998B (zh) * | 2015-11-04 | 2016-06-29 | 长春长生生物科技有限责任公司 | Hib综合培养基、b型流感嗜血杆菌结合疫苗及其制备方法 |
CN110251667A (zh) * | 2018-05-11 | 2019-09-20 | 武汉博沃生物科技有限公司 | 一种免疫组合制剂及其制备方法和应用 |
CN109001198A (zh) * | 2018-09-03 | 2018-12-14 | 艾美卫信生物药业(浙江)有限公司 | 脱氧胆酸钠沉淀法检测Hib结合疫苗中游离多糖的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101081296A (zh) * | 2006-05-29 | 2007-12-05 | 北京民海生物科技有限公司 | 一种b型流感嗜血杆菌荚膜多糖制备方法及其联合疫苗 |
CN101559222A (zh) * | 2009-05-31 | 2009-10-21 | 北京绿竹生物制药有限公司 | 人用细菌多糖-蛋白结合联合疫苗 |
EP2229954A1 (en) * | 2001-06-20 | 2010-09-22 | Novartis AG | Capsular polysaccharide solubilisation and combination vaccines |
EP2311488A2 (en) * | 2001-04-03 | 2011-04-20 | GlaxoSmithKline Biologicals s.a. | Vaccine composition |
CN102626515A (zh) * | 2012-04-23 | 2012-08-08 | 成都欧林生物科技股份有限公司 | b型流感嗜血杆菌多糖结合疫苗活化工艺 |
-
2012
- 2012-08-28 CN CN201210311027.3A patent/CN103623404B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2311488A2 (en) * | 2001-04-03 | 2011-04-20 | GlaxoSmithKline Biologicals s.a. | Vaccine composition |
EP2229954A1 (en) * | 2001-06-20 | 2010-09-22 | Novartis AG | Capsular polysaccharide solubilisation and combination vaccines |
CN101081296A (zh) * | 2006-05-29 | 2007-12-05 | 北京民海生物科技有限公司 | 一种b型流感嗜血杆菌荚膜多糖制备方法及其联合疫苗 |
CN101559222A (zh) * | 2009-05-31 | 2009-10-21 | 北京绿竹生物制药有限公司 | 人用细菌多糖-蛋白结合联合疫苗 |
CN102626515A (zh) * | 2012-04-23 | 2012-08-08 | 成都欧林生物科技股份有限公司 | b型流感嗜血杆菌多糖结合疫苗活化工艺 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2770877C1 (ru) * | 2021-04-08 | 2022-04-22 | Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" | Способ получения антигенной конъюгированной субстанции гемофильного типа b микроба для создания вакцинных препаратов |
Also Published As
Publication number | Publication date |
---|---|
CN103623404A (zh) | 2014-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103623404B (zh) | 一种b型流感嗜血杆菌多糖结合疫苗的制备方法 | |
CN103509756B (zh) | 一种牛支原体单克隆抗体及制备方法和应用 | |
CN102257127B (zh) | 使用二氧化碳控制肺炎链球菌多糖分子量的方法 | |
CN107266569B (zh) | 一种柞蚕丝素蛋白单克隆抗体的制备方法 | |
CN101590224A (zh) | 高效14价肺炎球菌结合疫苗 | |
CN106589127A (zh) | 一种pcsk9抗体及其制备方法和应用 | |
CN106062006B (zh) | 用于纯化多糖的新的下游方法 | |
CN102504043A (zh) | 保肝抗肝纤维化活性石斛多糖及其抗体亲和层析制备方法 | |
US20090060904A1 (en) | Vegetarian Protein A Preparation and Methods Thereof | |
NZ566871A (en) | Protein A Production and Purification without Using Animal Derived Components involving staphylococcus aureus | |
CN102775466A (zh) | 富硒酵母中含硒蛋白的制备方法 | |
US5989542A (en) | Capsular polysaccharides from enterococci | |
CN101441222B (zh) | 检测β伴大豆球蛋白的方法及其专用抗体与试剂盒 | |
CN105018435A (zh) | 一种病毒样颗粒的纯化方法 | |
CN103060275B (zh) | 一种抗氯胺酮杂交瘤细胞株及其制备方法和应用 | |
CN101045750B (zh) | 骆驼初乳免疫球蛋白IgA、IgG的提取工艺 | |
CN103627758B (zh) | 一种crm197蛋白的生产方法 | |
CN104311647A (zh) | 一种分离纯化百日咳毒素和丝状血凝素的方法 | |
Zanardo et al. | Development of a new process for purification of capsular polysaccharide from Streptococcus pneumoniae serotype 14 | |
TW202216736A (zh) | 用於生產水痘帶狀皰疹病毒之表面蛋白抗原的方法 | |
CN108570098B (zh) | 一种百日咳多种抗原成分的分离纯化方法 | |
CN103694334B (zh) | 一种制备hEGF粗制品的方法 | |
CN104387470B (zh) | 一种抗弓形虫单克隆抗体及其制备方法与应用 | |
CN102311498A (zh) | 一种从转基因哺乳动物乳液中分离重组人抗体的方法 | |
CN102417895A (zh) | 针对β伴大豆球蛋白β亚基的单克隆抗体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190515 Address after: 201203 No. 1 and No. 2 Juli Road, China (Shanghai) Free Trade Pilot Area, Pudong New Area, Shanghai Patentee after: Tian Shi Li biological medicine Limited by Share Ltd Address before: 300410 Tianjin Beichen District Huaihe road and Ting Jiang West Road intersection heaven proud of the park Legal Center Intellectual Property Department Patentee before: Tasly Pharmaceutical Group Limited by Share Ltd |